Relmada Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RLMD and other ETFs, options, and stocks.About RLMD
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications.
RLMD Key Statistics
Stock Snapshot
With a market cap of 453.94M, Relmada Therapeutics(RLMD) trades at $6.19. The stock has a price-to-earnings ratio of -3.52.
During the trading session on 2026-03-12, Relmada Therapeutics(RLMD) shares reached a daily high of $6.35 and a low of $5.95. At a current price of $6.19, the stock is +4.0% higher than the low and still -2.5% under the high.
Trading activity shows a volume of 890.87K, compared to an average daily volume of 5.21M.
The stock's 52-week range extends from a low of $0.24 to a high of $7.51.
The stock's 52-week range extends from a low of $0.24 to a high of $7.51.
RLMD News
Relmada Therapeutics (RLMD) stock surged on Monday after the clinical-stage biotechnology company announced two updates. The first one concerned its Phase 2 cli...
Relmada Therapeutics ( (RLMD) ) has provided an announcement. On March 9, 2026, Relmada Therapeutics agreed to raise approximately $160 million through a priva...
Relmada Therapeutics (RLMD) announced 12-month interim data from its ongoing Phase 2 trial evaluating NDV-01 in patients with high-risk non-muscle invasive blad...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.